Steven Cohen Senseonics Holdings, Inc. Transaction History

Point72 Asset Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.5 - $0.73 $129,516 - $189,094	259,033 Added 42.18%	873,199 $462,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $0.7 $235,334 - $343,196	-490,280 Reduced 44.39%	614,166 $350,000
Q3 2023 Nov 14, 2023	BUY	$0.5 - $1.05 $418,972 - $879,841	837,944 Added 314.42%	1,104,446 $662,000
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.89 $146,576 - $237,186	266,502 New	266,502 $202,000
Q1 2019 May 15, 2019	SELL	$2.3 - $3.27 $1.18 Million - $1.68 Million	-514,500 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.49 - $4.54 $777,801 - $1.42 Million	-312,370 Reduced 37.78%	514,500 $1.33 Million
Q3 2018 Nov 14, 2018	BUY	$3.4 - $4.84 $2.81 Million - $4 Million	826,870 New	826,870 $3.94 Million

141

59.5M

413K

212K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $163M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.